Zealand Pharma A/S (CPH: ZEAL)

Zealand Pharma Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	511.02	449.31	1,069	1,129	960.22	1,081
Short-Term Investments	8.9	-	-	-	-	299.45
Trading Asset Securities	7,961	1,184	108.61	299.04	297.35	-
Cash & Short-Term Investments	8,481	1,633	1,178	1,428	1,258	1,381
Cash Growth	436.03%	38.65%	-17.53%	13.56%	-8.91%	19.09%
Accounts Receivable	0.21	122.36	115.62	153.45	46.48	0.75
Other Receivables	165.91	16.44	21.6	21.56	15.44	15.04
Receivables	166.12	138.8	137.22	175.02	61.93	15.79
Inventory	0.8	7.94	1.29	118.44	65.04	-
Prepaid Expenses	34.87	-	-	-	35.16	30.76
Total Current Assets	8,718	1,780	1,316	1,722	1,420	1,427
Property, Plant & Equipment	128.92	149.85	165.49	221.45	213.04	125.34
Long-Term Investments	746.13	21.38	37.84	26.91	32.33	35.63
Other Intangible Assets	11.58	12.26	-	53.79	57.49	2.48
Long-Term Accounts Receivable	-	15.79	18.11	29.09	-	-
Long-Term Deferred Tax Assets	0.91	0.93	2.02	13.53	8.37	-
Other Long-Term Assets	23.88	-	-	1.27	31.04	9.01
Total Assets	9,630	1,980	1,540	2,068	1,762	1,600
Accounts Payable	229.7	91.61	180.76	266.39	70.38	57.53
Accrued Expenses	-	85.2	-	-	36.67	42.93
Current Portion of Leases	15.94	16.66	14.73	14.9	14.07	7.69
Current Income Taxes Payable	-	-	-	-	30.39	0.61
Current Unearned Revenue	-	-	-	53.03	53.18	56.25
Other Current Liabilities	-	91.12	-	-	150.56	30.12
Total Current Liabilities	245.63	284.58	195.49	334.32	355.26	195.13
Long-Term Debt	280.99	-	401.35	647.91	-	-
Long-Term Leases	92.57	102.58	108	124.63	116.05	78.07
Long-Term Unearned Revenue	-	-	-	14.55	44.59	83.64
Other Long-Term Liabilities	127.5	-	19.06	18.43	16.74	-
Total Liabilities	746.69	387.15	723.9	1,140	532.64	356.84
Common Stock	71.02	58.75	51.7	43.63	39.8	36.06
Additional Paid-In Capital	14,681	6,406	4,921	-	3,472	2,650
Retained Earnings	-5,891	-4,895	-4,172	-	-2,290	-1,444
Treasury Stock	-	-	-	-	-1.7	-
Comprehensive Income & Other	22.74	22.7	14.62	884.17	8.98	-
Shareholders' Equity	8,883	1,593	815.91	927.8	1,229	1,243
Total Liabilities & Equity	9,630	1,980	1,540	2,068	1,762	1,600
Total Debt	389.49	119.23	524.08	787.43	130.12	85.76
Net Cash (Debt)	8,815	1,514	653.77	640.72	1,127	1,295
Net Cash Growth	501.22%	131.55%	2.04%	-43.17%	-12.92%	11.69%
Net Cash Per Share	139.16	26.75	14.15	14.95	29.38	38.30
Filing Date Shares Outstanding	70.65	58.38	51.47	43.22	39.55	35.99
Total Common Shares Outstanding	70.65	58.38	51.47	43.22	39.74	35.99
Working Capital	8,473	1,495	1,121	1,387	1,064	1,232
Book Value Per Share	125.74	27.28	15.85	21.47	30.94	34.53
Tangible Book Value	8,872	1,581	815.91	874.01	1,172	1,240
Tangible Book Value Per Share	125.58	27.07	15.85	20.22	29.49	34.46
Buildings	-	-	-	-	34.1	13.77
Machinery	-	78.57	82.83	106.63	101.18	69.65
Construction In Progress	-	-	0.87	12.11	3.02	14
Leasehold Improvements	-	38.91	38.19	36.6	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.